Overview

Double-Blind Trial of Miglitol in Type 2 Diabetic Patients Treated With Biguanide

Status:
Completed

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the clinical efficacy and safety of Miglitol in patients with Type2 Diabetes Mellitus treated with Biguanide.

Phase:

Phase 3

Details

Lead Sponsor:

Sanwa Kagaku Kenkyusho Co., Ltd.

Treatments:

Miglitol